"Innovative Solutions for Cell Processing"
2025 | 2024 | 2023 |
Corporate Partnership with Inha University Hospital Open Lab. Initiation of Tissue Preprocessing Equipment Development. | Selected for the R&D Program by the Ministry of SMEs and Startups. Developing a Large-Scale Exosome Production Platform Certified as a Venture Company GMP and ISO 13485 Certified Class III Medical Device Approval | Selected for the R&D Program by the Ministry of SMEs and Startups. Exosome R&D Investment Attraction / Fundraising |
2022 | 2021 | |
Company Founded | Selected for the R&D Program by the Ministry of SMEs and Startups. Initiating the Development of Enzyme-Free Stem Cell Isolation Equipment. |